• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

处于、面对及超越风险:对未来可能患痴呆症的生活期望。

At, with and beyond risk: expectations of living with the possibility of future dementia.

作者信息

Milne Richard, Diaz Ana, Badger Shirlene, Bunnik Eline, Fauria Karine, Wells Katie

机构信息

Institute of Public Health, University of Cambridge, UK.

Alzheimer Europe, Luxembourg.

出版信息

Sociol Health Illn. 2018 Jul;40(6):969-987. doi: 10.1111/1467-9566.12731. Epub 2018 Apr 16.

DOI:10.1111/1467-9566.12731
PMID:29659032
Abstract

Biomedical research aimed at the development of therapies for chronic and late-onset conditions increasingly concentrates on the early treatment of symptom-less disease. This broad trend is evidenced in prominent shifts in contemporary dementia research. Revised diagnostic criteria and new approaches to clinical trials propose a focus on earlier stages of disease and prompt concerns about the implications of communicating test results associated with the risk of developing dementia when no effective treatments are available. This article examines expectations of the implications of learning test results related to dementia risk, based on focus group research conducted in the UK and Spain. It points to the extended social and temporal aspects of the dementia risk experience. Three key dimensions of this risk experience are elaborated: living 'at risk', represented in efforts to reduce risk and plan for the future; 'with risk', through vigilance towards cognitive health and earlier or prolonged contact with healthcare services; and finally, 'beyond risk' through a cessation of the self in its current social, legal and financial form. A virtual abstract of this paper can be viewed at: https://www.youtube.com/channel/UC_979cmCmR9rLrKuD7z0ycA.

摘要

旨在开发慢性和迟发性疾病治疗方法的生物医学研究越来越关注无症状疾病的早期治疗。当代痴呆症研究的显著转变就证明了这一广泛趋势。修订后的诊断标准和新的临床试验方法建议将重点放在疾病的早期阶段,并引发了人们对在没有有效治疗方法的情况下传达与患痴呆症风险相关的检测结果所带来影响的担忧。本文基于在英国和西班牙进行的焦点小组研究,探讨了对了解与痴呆症风险相关的检测结果所产生影响的期望。它指出了痴呆症风险经历在社会和时间方面的延伸。阐述了这种风险经历的三个关键维度:“处于风险中”生活,体现在降低风险和为未来做规划的努力中;“伴随着风险”,通过对认知健康的警惕以及更早或更长时间地接触医疗服务来体现;最后,“超越风险”,即通过停止当前社会、法律和经济形式下的自我来实现。本文的虚拟摘要可在以下网址查看:https://www.youtube.com/channel/UC_979cmCmR9rLrKuD7z0ycA 。

相似文献

1
At, with and beyond risk: expectations of living with the possibility of future dementia.处于、面对及超越风险:对未来可能患痴呆症的生活期望。
Sociol Health Illn. 2018 Jul;40(6):969-987. doi: 10.1111/1467-9566.12731. Epub 2018 Apr 16.
2
Perspectives on Communicating Biomarker-Based Assessments of Alzheimer's Disease to Cognitively Healthy Individuals.对认知健康个体进行阿尔茨海默病生物标志物评估的沟通视角。
J Alzheimers Dis. 2018;62(2):487-498. doi: 10.3233/JAD-170813.
3
[Awareness disorders in Alzheimer's disease and in mild cognitive impairment].[阿尔茨海默病和轻度认知障碍中的意识障碍]
Encephale. 2014 Apr;40(2):180-7. doi: 10.1016/j.encep.2013.10.003. Epub 2014 Mar 11.
4
[The new 2011 recommendations of the National Institute on Aging and the Alzheimer's Association on diagnostic guidelines for Alzheimer's disease: Preclinal stages, mild cognitive impairment, and dementia].[美国国立衰老研究所和阿尔茨海默病协会关于阿尔茨海默病诊断指南的2011年新建议:临床前阶段、轻度认知障碍和痴呆症]
Rev Neurol (Paris). 2012 Jun;168(6-7):471-82. doi: 10.1016/j.neurol.2011.11.007. Epub 2012 May 12.
5
Shifting dementia discourses from deficit to active citizenship.将痴呆症话语从缺陷转向积极公民身份。
Sociol Health Illn. 2017 Feb;39(2):199-211. doi: 10.1111/1467-9566.12530.
6
7
Dependence Levels as Interim Clinical Milestones Along the Continuum of Alzheimer's Disease: 18-Month Results from the GERAS Observational Study.阿尔茨海默病连续体中的依赖程度作为临时临床里程碑:来自 GERAS 观察性研究的 18 个月结果。
J Prev Alzheimers Dis. 2017;4(2):72-80. doi: 10.14283/jpad.2017.2.
8
Early assessment for Alzheimer's disease and dementia: comparison of two metamemory diagnostic tests.阿尔茨海默病和痴呆症的早期评估:两种元记忆诊断测试的比较
J Psychosoc Nurs Ment Health Serv. 2013 Sep;51(9):17-21. doi: 10.3928/02793695-20130731-01. Epub 2013 Aug 16.
9
[Map of Alzheimer's disease and other dementias in Spain. MapEA Project].[西班牙阿尔茨海默病及其他痴呆症地图。MapEA项目]
Rev Esp Geriatr Gerontol. 2018 Jan-Feb;53(1):26-37. doi: 10.1016/j.regg.2017.07.006. Epub 2017 Oct 27.
10
Dementia and mild cognitive impairment in adults with intellectual disability: issues of diagnosis.成年智障者的痴呆与轻度认知障碍:诊断问题
Dev Disabil Res Rev. 2013;18(1):31-42. doi: 10.1002/ddrr.1126.

引用本文的文献

1
The Use and Understanding of Mild Cognitive Impairment in Routine Specialist Care: A Survey Among German Memory Clinics.常规专科护理中轻度认知障碍的应用与理解:德国记忆诊所的一项调查
Geriatrics (Basel). 2025 Feb 2;10(1):21. doi: 10.3390/geriatrics10010021.
2
The PREVENT dementia programme: baseline demographic, lifestyle, imaging and cognitive data from a midlife cohort study investigating risk factors for dementia.预防痴呆症项目:一项中年队列研究的基线人口统计学、生活方式、影像学和认知数据,该研究调查痴呆症的风险因素。
Brain Commun. 2024 May 31;6(3):fcae189. doi: 10.1093/braincomms/fcae189. eCollection 2024.
3
Ethical issues when using digital biomarkers and artificial intelligence for the early detection of dementia.
使用数字生物标志物和人工智能进行痴呆症早期检测时的伦理问题。
Wiley Interdiscip Rev Data Min Knowl Discov. 2023 May-Jun;13(3):e1492. doi: 10.1002/widm.1492. Epub 2023 Feb 19.
4
The Return of Biomarker Results in Research: Balancing Complexity, Precision, and Ethical Responsibility.研究中生物标志物结果的回归:平衡复杂性、精确性和伦理责任。
J Alzheimers Dis. 2024;97(3):1083-1090. doi: 10.3233/JAD-230359.
5
Intelligent digital tools for screening of brain connectivity and dementia risk estimation in people affected by mild cognitive impairment: the AI-Mind clinical study protocol.用于筛查轻度认知障碍患者脑连接性和痴呆风险评估的智能数字工具:AI-Mind临床研究方案
Front Neurorobot. 2024 Jan 5;17:1289406. doi: 10.3389/fnbot.2023.1289406. eCollection 2023.
6
Biomarkers of aging.衰老的生物标志物。
Sci China Life Sci. 2023 May;66(5):893-1066. doi: 10.1007/s11427-023-2305-0. Epub 2023 Apr 11.
7
Digital phenotyping and the (data) shadow of Alzheimer's disease.数字表型与阿尔茨海默病的(数据)阴影
Big Data Soc. 2022 Jan;9(1):20539517211070748. doi: 10.1177/20539517211070748. Epub 2022 Jan 11.
8
People's interest in brain health testing: Findings from an international, online cross-sectional survey.人们对大脑健康测试的兴趣:一项国际在线横断面调查的结果。
Front Public Health. 2022 Oct 20;10:998302. doi: 10.3389/fpubh.2022.998302. eCollection 2022.
9
Data-driven causal model discovery and personalized prediction in Alzheimer's disease.阿尔茨海默病中数据驱动的因果模型发现与个性化预测
NPJ Digit Med. 2022 Sep 8;5(1):137. doi: 10.1038/s41746-022-00632-7.
10
What Influences the Willingness of Blacks and African Americans to Enroll in Preclinical Alzheimer's Disease Biomarker Research? A Qualitative Vignette Analysis.哪些因素影响黑人和非裔美国人参与临床前期阿尔茨海默病生物标志物研究的意愿?一项定性情境分析。
J Alzheimers Dis. 2022;87(3):1167-1179. doi: 10.3233/JAD-215521.